Also known as: Trastuzumab / Herceptin
Trastuzumab (Herceptin) is a recombinant humanized monoclonal antibody targeting the HER2/neu receptor. It is used in the treatment of HER2-positive breast cancer and gastric cancer. Mediocon Inc supplies pharmaceutical-grade Trastuzumab API with full batch documentation.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | ≥95.0% (by SDS-PAGE) |
| Loss on Drying | NMT 5.0% |
| Heavy Metals | NMT 20 ppm |
| pH | 6.0 – 7.0 (reconstituted) |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Packing | 25 kg HDPE drums / as per requirement |